77 related articles for article (PubMed ID: 10876166)
1. Structure-specific effects of thyroxine analogs on human liver 3 alpha-hydroxysteroid dehydrogenase.
Yamamoto T; Nozaki A; Shintani S; Ishikura S; Katagiri Y; Hara A
J Biochem; 2000 Jul; 128(1):121-8. PubMed ID: 10876166
[TBL] [Abstract][Full Text] [Related]
2. Involvement of two basic residues (Lys-270 and Arg-276) of human liver 3 alpha-hydroxysteroid dehydrogenase in NADP(H) binding and activation by sulphobromophthalein: site-directed mutagenesis and kinetic analysis.
Matsuura K; Tamada Y; Sato K; Iwasa H; Miwa G; Deyashiki Y; Hara A
Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):89-93. PubMed ID: 9078247
[TBL] [Abstract][Full Text] [Related]
3. Kinetic alteration of a human dihydrodiol/3alpha-hydroxysteroid dehydrogenase isoenzyme, AKR1C4, by replacement of histidine-216 with tyrosine or phenylalanine.
Ohta T; Ishikura S; Shintani S; Usami N; Hara A
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):685-91. PubMed ID: 11104674
[TBL] [Abstract][Full Text] [Related]
4. Expression and kinetic properties of a recombinant 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase isoenzyme of human liver.
Deyashiki Y; Tamada Y; Miyabe Y; Nakanishi M; Matsuura K; Hara A
J Biochem; 1995 Aug; 118(2):285-90. PubMed ID: 8543560
[TBL] [Abstract][Full Text] [Related]
5. Activation of human liver 3 alpha-hydroxysteroid dehydrogenase by sulphobromophthalein.
Matsuura K; Tamada Y; Deyashiki Y; Miyabe Y; Nakanishi M; Ohya I; Hara A
Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):179-84. PubMed ID: 8546681
[TBL] [Abstract][Full Text] [Related]
6. Binding of thyroxine analogs to human liver aldehyde dehydrogenases.
Zhou J; Weiner H
Eur J Biochem; 1997 Apr; 245(1):123-8. PubMed ID: 9128732
[TBL] [Abstract][Full Text] [Related]
7. Mutagenesis of 3 alpha-hydroxysteroid dehydrogenase reveals a "push-pull" mechanism for proton transfer in aldo-keto reductases.
Schlegel BP; Jez JM; Penning TM
Biochemistry; 1998 Mar; 37(10):3538-48. PubMed ID: 9521675
[TBL] [Abstract][Full Text] [Related]
8. The arginine 276 anchor for NADP(H) dictates fluorescence kinetic transients in 3 alpha-hydroxysteroid dehydrogenase, a representative aldo-keto reductase.
Ratnam K; Ma H; Penning TM
Biochemistry; 1999 Jun; 38(24):7856-64. PubMed ID: 10387026
[TBL] [Abstract][Full Text] [Related]
9. Dual effects of anti-inflammatory 2-arylpropionic acid derivatives on a major isoform of human liver 3alpha-hydroxysteroid dehydrogenase.
Yamamoto T; Matsuura K; Shintani S; Hara A; Miyabe Y; Sugiyama T; Katagiri Y
Biol Pharm Bull; 1998 Nov; 21(11):1148-53. PubMed ID: 9853403
[TBL] [Abstract][Full Text] [Related]
10. Kinetic studies of the inhibition of a human liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase isozyme by bile acids and anti-inflammatory drugs.
Miyabe Y; Amano T; Deyashiki Y; Hara A; Tsukada F
Biol Pharm Bull; 1995 Jan; 18(1):9-12. PubMed ID: 7735258
[TBL] [Abstract][Full Text] [Related]
11. Activation of human liver 3alpha-hydroxysteroid dehydrogenase by clofibrate derivatives.
Matsuura K; Hara A; Kato M; Deyashiki Y; Miyabe Y; Ishikura S; Sugiyama T; Katagiri Y
J Pharmacol Exp Ther; 1998 Jun; 285(3):1096-103. PubMed ID: 9618412
[TBL] [Abstract][Full Text] [Related]
12. Human liver class I alcohol dehydrogenase gammagamma isozyme: the sole cytosolic 3beta-hydroxysteroid dehydrogenase of iso bile acids.
Marschall HU; Oppermann UC; Svensson S; Nordling E; Persson B; Höög JO; Jörnvall H
Hepatology; 2000 Apr; 31(4):990-6. PubMed ID: 10733557
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of 3 alpha(17 beta)-hydroxysteroid dehydrogenase distinct from 3 alpha-hydroxysteroid dehydrogenase in hamster liver.
Ohmura M; Hara A; Nakagawa M; Sawada H
Biochem J; 1990 Mar; 266(2):583-9. PubMed ID: 2317205
[TBL] [Abstract][Full Text] [Related]
14. Kinetic and stereochemical characterization of hamster liver 3 alpha-hydroxysteroid dehydrogenase and 3 alpha(17 beta)-hydroxysteroid dehydrogenase.
Sawada H; Hara A; Ohmura M; Nakayama T; Deyashiki Y
J Biochem; 1991 May; 109(5):770-5. PubMed ID: 1917902
[TBL] [Abstract][Full Text] [Related]
15. Interaction between thyroid hormones and erythrocyte membranes: competitive inhibition of binding 131 I-L-triiodothyronine and 131 I-L-thyroxine by their analogs.
Singh SP; Carter AC; Kydd DM; Costanzo RR
Endocr Res Commun; 1976; 3(2):119-31. PubMed ID: 182449
[TBL] [Abstract][Full Text] [Related]
16. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones.
Penning TM; Burczynski ME; Jez JM; Hung CF; Lin HK; Ma H; Moore M; Palackal N; Ratnam K
Biochem J; 2000 Oct; 351(Pt 1):67-77. PubMed ID: 10998348
[TBL] [Abstract][Full Text] [Related]
17. Thyroxine-protein interactions. Binding constants for interaction of thyroxine analogues with the thyroxine binding site on human thyroxine-binding globulin.
Tabachnick M; Korcek L
Biochim Biophys Acta; 1978 Nov; 537(1):169-75. PubMed ID: 102364
[TBL] [Abstract][Full Text] [Related]
18. Structure/function aspects of human 3beta-hydroxysteroid dehydrogenase.
Thomas JL; Duax WL; Addlagatta A; Kacsoh B; Brandt SE; Norris WB
Mol Cell Endocrinol; 2004 Feb; 215(1-2):73-82. PubMed ID: 15026177
[TBL] [Abstract][Full Text] [Related]
19. Identification of a principal mRNA species for human 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity.
Matsuura K; Shiraishi H; Hara A; Sato K; Deyashiki Y; Ninomiya M; Sakai S
J Biochem; 1998 Nov; 124(5):940-6. PubMed ID: 9792917
[TBL] [Abstract][Full Text] [Related]
20. Kinetic mechanisms in the reduction of aldehydes and ketones catalyzed by rabbit liver aldehyde reductases and hydroxysteroid dehydrogenases.
Sawada H; Hara A; Nakayama T; Hayashibara M
J Biochem; 1982 Jul; 92(1):185-91. PubMed ID: 6749832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
